SYSTEM 50 FLUID

Principle Routes of Exposure

INHALATION: Excessive inhalation may produce symptoms of central nervous system depression ranging from light-headedness. nausea and vomiting. to unconsciousnesS and death. SKIN: Mildly irritating. May produce a burning sensation. # Prolonged or repeated contact may redden. roughen. and dry due to the removal of natural oils and may result in dermatitis. May be absorbed through the skin. although not expected to produce tax ic i ty through th i_s route. EYE CONTACT: An irritant causing pain. lacrimation. and general inflammation. INGESTION: May cause irritation of the gastrOintestinal tract with vomiting. If vomiting results in aspiration. chemical pneumonia could follow. Absorption through the gastrOintestinal tract may produce symptoms of central nervous system depreSSion ranging from light-headedness to unconsciousness. EFFECTS OF OVEREXPOSURE ACUTE: ExceSSive inhalation or ingestion may produce symptoms of central nervous system depression ranging from light-headedness. to unconsciousness and death. Overexposure may result in liver and kidney damage. Exposure of the eyes and skin may produce. irritation. CHRONIC: Can cause headache. mental confusion. depression. fatigue. loss of appetite. nausea. vomiting. cough. loss of sense of balance. and visual disturbances. Prolonged or repeated skin contact may cause dermatitis.

Health hazards

DATA Acute Oral LOS0 2.6 gm/kg (rat) Acute Inhalation LOS0 = 5040 ppm. 34.2 mgll for 8 hrs (rat) IARC Lists this product as having inadequate eVidence in human and limited evidence in animals to evaluate carcinogenicity. (Group 3). A 1986 National Toxicology Program report 'notes that PERC when administered via inhalation to rats and mice produce "clear evidence of carcinogenicity" in male rats (mononuclear cell leukemia and kidney tumors) and in male and female mice (liver tumors) . The inh ib i tors in this product are not considered toxic nor carcinogenic by IARC. NTP.